not tagged
asher bio
['advance']
sfbn feed: asher bio presents new preclinical data at sitc 2022 further supporting advancement of ab248 and ab821 as highly differentiated cis-targeted cancer immunotherapies: south san francisco, ... #bayarea #biotech 